Latest headlines across the TrendMatrix universe. Sentiment-scored, tickered, deduped. Updated every 5 minutes.
Compass CEO Warns Housing Market Is Splitting Apart as 42% of Homes See Price Cuts, Highest in Nearly a Decade: 'There's
'Freaking Insane': Daniel Newman Says Chinese AI Labs 'Lifted' US Frontier Models As Anthropic Accuses Alibaba, DeepSeek
Sunbelt Rentals Analysts Boost Their Forecasts After Upbeat Q1 Earnings
Morgan Stanley Upgrades Lineage to Overweight, Maintains Price Target to $47
Compass Pathways’ Psilocybin Treatment Shows Lasting Benefits in Treatment-Resistant Depression
ZWS Maintained by Oppenheimer -- Price Target Raised to $60 - GuruFocus
Leerink Partners Initiates Coverage On Viatris with Outperform Rating, Announces Price Target of $20
Energy Transfer: Energy Revolution Drives Multi-Year Backlog Growth - Reiterate Buy - Seeking Alpha
Stifel Maintains Buy on Revolution Medicines, Raises Price Target to $230
TD Cowen Maintains Buy on Roivant Sciences, Raises Price Target to $55
Stratasys Launches Its F870 FDM System Large-Format Additive Manufacturing Platform At Toyota And Rivian Factories In Th
The FDA Grants Regenerative Medicine Advanced Therapy Designation to Autolus Therapeutics' Obecabtagene Autoleucel for S
Morgan Stanley Upgrades Flagstar Bank to Overweight, Raises Price Target to $17
Rigetti Computing Announces Definitive Agreement With Commerce Department For $100M CHIPS Act Award To Accelerate Superc
Quantinuum Finalized $100M CHIPS Funding From U.S. Department Of Commerce
Definium Therapeutics Receives FDA Breakthrough Therapy Designation For DT120 ODT; Second Breakthrough Therapy Designati
HC Wainwright & Co. Reiterates Buy on Scholar Rock Holding, Maintains $65 Price Target
Cathie Wood Says AI Revolution Could Supercharge Global Growth — TSLA, COIN and CRSP Stocks Are Among Her Top Bets
HC Wainwright & Co. Reiterates Buy on Oruka Therapeutics, Maintains $120 Price Target
Wolfe Research Initiates Coverage On Hyatt Hotels with Outperform Rating, Announces Price Target of $203